X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   ACTAVIS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
ACTAVIS
Dec-14
UNICHEM LAB/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs32018,501-   
Low Rs22111,285-   
Sales per share (Unadj.) Rs167.23,331.6-  
Earnings per share (Unadj.) Rs12.0-415.7-  
Cash flow per share (Unadj.) Rs16.9305.7-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs117.07,226.1-  
Shares outstanding (eoy) m90.88265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.64.5 36.2%   
Avg P/E ratio x22.6-35.8 -63.1%  
P/CF ratio (eoy) x16.048.7 32.8%  
Price / Book Value ratio x2.32.1 112.1%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m24,5783,960,121 0.6%   
No. of employees `0005.221.6 24.0%   
Total wages/salary Rs m2,4870-   
Avg. sales/employee Rs Th2,928.341,012.3 7.1%   
Avg. wages/employee Rs Th479.40-   
Avg. net profit/employee Rs Th209.4-5,117.9 -4.1%   
INCOME DATA
Net Sales Rs m15,195885,865 1.7%  
Other income Rs m110-2,211 -5.0%   
Total revenues Rs m15,305883,654 1.7%   
Gross profit Rs m1,788113,802 1.6%  
Depreciation Rs m452191,822 0.2%   
Interest Rs m3427,942 0.1%   
Profit before tax Rs m1,413-108,173 -1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-7,935 0.0%   
Tax Rs m326-5,561 -5.9%   
Profit after tax Rs m1,087-110,547 -1.0%  
Gross profit margin %11.812.8 91.6%  
Effective tax rate %23.15.1 448.6%   
Net profit margin %7.2-12.5 -57.3%  
BALANCE SHEET DATA
Current assets Rs m6,426466,737 1.4%   
Current liabilities Rs m3,917340,389 1.2%   
Net working cap to sales %16.514.3 115.8%  
Current ratio x1.61.4 119.6%  
Inventory Days Days6858 116.6%  
Debtors Days Days7766 116.1%  
Net fixed assets Rs m7,410108,173 6.8%   
Share capital Rs m1820-   
"Free" reserves Rs m10,4540-   
Net worth Rs m10,6361,921,408 0.6%   
Long term debt Rs m41,006,856 0.0%   
Total assets Rs m15,2583,521,309 0.4%  
Interest coverage x42.9-2.9 -1,494.7%   
Debt to equity ratio x00.5 0.1%  
Sales to assets ratio x1.00.3 395.9%   
Return on assets %7.3-2.3 -313.1%  
Return on equity %10.2-5.8 -177.6%  
Return on capital %13.6-3.0 -451.4%  
Exports to sales %24.10-   
Imports to sales %4.90-   
Net fx Rs m5,2980-   
CASH FLOW
From Operations Rs m683152,120 0.4%  
From Investments Rs m-1,316-364,234 0.4%  
From Financial Activity Rs m592204,647 0.3%  
Net Cashflow Rs m-40-7,467 0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 67.82 Rs / USD

Compare UNICHEM LAB With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: CADILA HEALTHCARE  AJANTA PHARMA  STERLING BIOTECH  ALEMBIC PHARMA  FDC LTD.  



Today's Market

Sensex Opens Flat; Energy Stocks Lose(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.4% while the Hang Seng is down 0.5%. The Shanghai Composite is trading up by 0.2%.

Related Views On News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jun 25, 2018 12:53 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS